Project Grant R01CA293884
Award Date 8/7/25
Completion Date 7/31/29
Dollars Obligated $2.2M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Pennsylvania, USA
Similar Awards
- This $129,480 Project Grant, awarded on December 1, 2024 by the National Cancer Institute (CFDA 93.398 Cancer Research Manpower), aims to examine tobacco use relapse among cancer survivors. The study will recruit 122 cancer survivors at high risk of relapse from the VCU Massey Cancer Center to complete surveys assessing intrapersonal factors (e.g., cancer worry, negative affect) and interpersonal factors (e.g., social support, social constraint) as predictors of tobacco use relapse. A subset...
- This Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) provides $395,248.00 to Virginia Polytechnic Institute & State University (Virginia Tech) to conduct research on "Generalized and Cancer-Related Episodic Future Thinking for Smoking Cessation: Proof-of-Concept and Feasibility Testing." The research aims to develop an intervention using episodic future thinking to shift smokers' time perspective and reduce their bias...
- The National Cancer Institute (NCI) awarded a Project Grant under the Cancer Cause and Prevention Research program (CFDA 93.393) to the University of Oklahoma Health Sciences Center to conduct a randomized factorial trial on smoking cessation interventions. The $625,201 award, effective January 1, 2025 through December 31, 2029, will evaluate the combined impact of varenicline medication plus nicotine lozenges, and a smartphone-based medication adherence intervention, on 7-day point prevalence...
- The University of Alabama was awarded a $2,524,071 Project Grant by the National Cancer Institute (CFDA 93.393 Cancer Cause and Prevention Research) on September 23, 2025. The grant supports a research project to investigate the neural mechanisms that underlie self-regulation and reinforcement learning in smoking decisions among e-cigarette or other electronic nicotine delivery system users. The study will use computational modeling, multi-modal neuroimaging (EEG, fMRI), and custom-made...
- The federal Project Grant award titled "Catalyzing Cigarette Smoking Cessation Through Harm Reduction Sampling Among People Unmotivated to Quit" is funded by the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) for $663,554.00 with an award date of August 18, 2025 and an ultimate completion date of July 31, 2030. The grant supports research to explore the use of harm reduction product sampling, such as e-cigarettes, heated tobacco products, and oral...
- This federal Project Grant award, funded by the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research), is focused on developing a cue-based smoking cessation intervention delivered via telehealth for people who smoke lightly (PSLI). The $906,306 award, with a performance period from September 2025 to August 2028, aims to adapt and pilot test an intervention that combines cue-based treatment with standard cognitive behavioral therapy (CBT) to promote smoking cessation...
- This federal Project Grant award of $619,175 from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) supports a Type 1 hybrid effectiveness-implementation trial to evaluate a novel harm reduction approach for oncology outpatients who smoke but refuse traditional tobacco treatment. The study will directly compare rates of switching from cigarettes to e-cigarettes against standard care, while also assessing key barriers and facilitators to implementation. The...
- This federal Project Grant award of $164,484.00 from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) supports the development and evaluation of smoking cessation messages targeted to adults who smoke nondaily. The project, conducted by the University of Kentucky Research Foundation, aims to create tailored communications that increase knowledge, worry, risk perceptions, motivation, and intentions to quit smoking among this population. The researchers will...
- This Project Grant award from the National Cancer Institute (NCI), under the Cancer Cause and Prevention Research program (CFDA 93.393), provides $594,099 to Brown University to characterize young adult dual users of marijuana and tobacco using novel behavioral economic measures. The 4-year project aims to better understand the behavioral mechanisms underlying this prevalent and risky pattern of substance use, which is associated with increased cancer risk across the lifespan. Key objectives...
- The University of Pittsburgh received a $585,931 Project Grant award from the National Cancer Institute (CFDA 93.396 - Cancer Biology Research) on February 3, 2025. The grant will fund a comprehensive research framework to determine the molecular credentials and selection of cancer models, such as cell lines, patient-derived xenografts (PDX), and patient-derived organoids (PDO), to guide translational and clinical applications in breast cancer. The key objectives are: (1) identifying and...